Also known as

MT-2 · MT2 · Melanocortin receptor agonist

Overview

Melanotan-2 is a cyclic melanocortin receptor agonist studied in pigmentation (melanogenesis) and melanocortin-behavior research. Literature also notes significant autonomic and nausea-related side-effect profiles in human-exposure reports—relevant as research context, not as use guidance.

Laboratory catalogs carry it for MC1R/MC4R pathway work. Left Turn Adventures supplies this compound for laboratory and research use only.

Proven benefits

Note: Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.

• Melanogenesis and pigmentation endpoints

• • MC1R/MC4R receptor pharmacology markers

• • Melanocortin-behavior and appetite-adjacent readouts where studied

• • UV-response research co-markers

• • Comparative melanocortin agonist work versus MT-1 and PT-141

Results timeline

Note: Illustrative research-observation windows — not a clinical schedule. No dosing.

• Week 1–2: Early melanocortin or gonadal-axis signaling in acute models.

• • Week 3–4: Clearer arousal, pigmentation, or hormone-axis markers in short research windows.

• • Month 2–3: More stable pathway and behavioral endpoints in extended preclinical designs.

• • Month 3–6: Sustained melanocortin or reproductive-axis observations where longer windows are used.

The catalog, not a clinic

For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.